AI Applications in the Drug Development Pipeline
Examines how AI accelerates the pharmaceutical drug pipeline, reducing time to market. Updated for 2026 with the latest clinical milestones, FDA guidance, and industry developments including Insilico Medicine's Phase IIa results and the Recursion-Exscientia merger.